Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
11/17/23 16:55 | 11/16/23 | LXRX | Health | Drug | Pharmaceutical Preparations | Coats Lonnel | TX | DO | CEO | 5 | P.m | 266 | 1.56 | 0 | 170 | 23 | 914 | D | ||||||||||||||
10/12/23 16:01 | 10/10/23 | LXRX | Health | Drug | Pharmaceutical Preparations | Debbane Raymond | TX | D | 1 | P.m | 1,104 | 1.10 | 0 | 1,000 | 17 | 6,792 | D | |||||||||||||||
9/14/23 17:05 | 9/14/23 | LXRX | Health | Drug | Pharmaceutical Preparations | Wade Jeffrey L | TX | O | P,CFO | 2 | P | 42 | 1.90 | 0 | 22 | 9 | 264 | D | ||||||||||||||
8/7/23 16:13 | 8/4/23 | LXRX | Health | Drug | Pharmaceutical Preparations | McDermott Wendy | TX | O | VP,HR | 2 | P | 35 | 2.21 | 0 | 16 | 128 | 28 | D | ||||||||||||||
6/5/23 16:46 | 6/5/23 | LXRX | Health | Drug | Pharmaceutical Preparations | Artal International S.C.A. | N4 | DT | 1 | P | 72,215 | 2.60 | 0 | 27,775 | 31 | 117,553 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |